Obstetrics/Gynecology
RSSArticles
Thank You, Molly Brewer; Welcome Melissa Moffitt
Progesterone: Not a Treatment for Threatened Abortion
Investigators of this well-designed, randomized, controlled trial conclusively demonstrated that progesterone supplementation does not reduce the risk of early pregnancy loss in women who experience first trimester bleeding.
Should Antibiotic Prophylaxis Be Used for Surgical Treatment of Early Pregnancy Loss?
In this randomized, controlled trial of more than 3,000 women in developing countries with incomplete or missed abortion at less than 22 weeks’ gestation, antibiotic prophylaxis prior to uterine evacuation reduced infection rates when a strict definition for pelvic infection was used, but not when a more expanded definition was used.
Behavioral Interventions for Menopausal-Related Insomnia Improve Depression
In a randomized, controlled trial comparing the behavioral interventions cognitive behavioral therapy for insomnia (CBTI) and sleep reduction therapy (SRT) to a control intervention of sleep hygiene education, investigators found CBTI and SRT therapy improved insomnia and depressive symptoms in postmenopausal women with menopausal-related insomnia.
Changes in Cervical Cancer Staging
This paper is an epidemiologic validation of recent changes in cervical cancer staging.
Annual User Survey
Drug Combination Considered for Treatment-Resistant Gonorrhea
Newly released research indicates that a certain combination of drugs, gentamicin and azithromycin, may work as well as ceftriaxone alone for cases of drug-resistant gonorrhea.
Time to Close Gaps in HIV Testing, Treatment
About 80% of new HIV transmissions can be linked to people whose infection is undiagnosed or is not currently treated, according to findings from a just-published analysis.
Legislators, Listen Up, Learn, and Perhaps Beware
Combined oral contraceptives have been shown to provide health benefits beyond birth control.
Science Focuses on the Use of Metronidazole for Endometriosis
Researchers are exploring the use of metronidazole for the treatment of endometriosis, which affects up to 10% of U.S. women between the ages of 25 and 40. The current treatment options include hormone therapy and surgery, but these approaches involve significant side effects and recurrence of the condition after treatment.